This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Olon S.p.a., Farmitalia Carlo Erba. Active years: 1986-2018.
Company Filing History:
Years Active: 1986-2018
Title: Giovanni Lazzari: Innovator in Tiacumicin B Research
Introduction
Giovanni Lazzari is a notable inventor based in Settimo Torinese, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development and purification of tiacumicin B. With a total of 3 patents to his name, Lazzari's work has the potential to impact commercial production processes in the pharmaceutical industry.
Latest Patents
Lazzari's latest patents include a process for preparing novel forms of tiacumicin B. This invention relates to obtaining tiacumicin B with a well-defined crystal habit and particle size. The process involves repeating cycles of heating and cooling under controlled conditions of temperature and stirring. Another significant patent is for a procedure for the purification of tiacumicin B. This improved process simplifies the purification of tiacumicin B from fermentation broth using chromatography techniques. It specifically includes a method for purifying tiacumicin B by subjecting a liquid containing it to at least one hydrophobic interaction chromatography step. This process is designed to be simpler than previous methods and is suitable for large-scale commercial production.
Career Highlights
Throughout his career, Giovanni Lazzari has worked with reputable companies in the pharmaceutical sector. Notable among these are Olon S.p.a. and Farmitalia Carlo Erba. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.
Collaborations
Lazzari has collaborated with several professionals in his field, including Piera Fonte and Ernesto Oppici. These collaborations have likely enriched his research and contributed to the successful development of his patents.
Conclusion
Giovanni Lazzari is a distinguished inventor whose work in tiacumicin B research showcases his innovative spirit and dedication to advancing pharmaceutical processes. His contributions are poised to make a significant impact in the industry.